Cantel Medical Corp. (NYSE:CMD) moved up to the S&P 400 MidCap index, effective March 19, 2018, as a result of its strong financial performance and continued growth. Click here to read more.
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2018. Click here to read more.
Cantel Medical is a global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers, which improve outcomes and help save lives. Through an expansive portfolio of endoscopy, water purification and filtration, and healthcare disposables, Cantel Medical provides high-quality infection prevention solutions and unsurpassed service, touching millions of patients each year around the world.